Maternal Alopecia Areata associated with autoimmune, atopic, thyroid, and psychiatric disorders in offsprings:JAMA Dr. Shravani Dali31 May 2023 9:15 AM ISTMaternal Alopecia Areata associated with autoimmune, atopic, thyroid, and psychiatric disorders in offsprings suggests anew study published in the...
Low-flavanol diet associated with age-related memory loss Dr. Kamal Kant Kohli30 May 2023 8:00 PM ISTResearchers at Columbia and Brigham and Women’s Hospital/Harvard have found in a new study that Low-flavanol diet is associated with age-related...
Ketamine noninferior to gold standard ECT for treating major depression: NEJM Dr. Kamal Kant Kohli30 May 2023 8:15 AM ISTUSA: For treating non-psychotic, treatment-resistant depression, a recent study found ketamine to be effective and noninferior to electroconvulsive...
Risk of mental disorders enhanced in elderly hospitalized patients of COVID 19 infection: JAMA Dr.Niharika Harsha B28 May 2023 8:00 PM ISTDenmark: New research revealed that individuals who were tested for SARS-CoV-2 had a greater chance of developing new mental health issues than those...
Children with T1D and psychiatric issues may have low Academic performance: JAMA Jacinthlyn Sylvia27 May 2023 10:30 AM ISTA new study published in the Journal of American Medical Association suggests that children and adolescents born in Sweden with type 1 diabetes (T1D)...
High-dose olanzapine safe against treatment-resistant schizophrenia Jacinthlyn Sylvia27 May 2023 9:30 AM ISTA new research by Louisa Gannon and colleagues offered preliminary support for the application of high-dose olanzapine in treatment-resistant...
Olanzapine superior to several antipsychotic drugs for long-term treatment of schizophrenia patients, study claims Medha Baranwal26 May 2023 11:15 AM ISTGermany: Olanzapine is more effective than several other antipsychotic drugs in the longer-term treatment of acutely ill schizophrenia patients,...
Ketamine found to be at least as effective as ECT for treating major depression Isra Zaman26 May 2023 9:15 AM ISTA new study led by investigators from Mass General Brigham has found that subanesthetic intravenous ketamine was effective and not inferior to...
Quality Improvement Program reduces Suicide Outcomes in the ED Jacinthlyn Sylvia24 May 2023 8:00 PM ISTIn the maintenance phase of the trial, there was a significantly lower incidence of suicide behaviors as a result of employing continuous quality...
Treatment of Depression with psychological therapy linked to lower cardiovascular disease risk Dr Monish Raut24 May 2023 9:45 AM ISTAccording to a research that was published in the European Heart Journal, treating depression with psychological therapies may lower the risk of...
FDA Approves Buprenorphine as New Treatment Option for Opioid Use Disorder Dr. Kamal Kant Kohli24 May 2023 9:30 AM ISTToday, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to...
Stopping cannabis can help prevent schizophrenia in 25% young adults Dr. Shravani Dali23 May 2023 8:15 AM ISTStudies in the past suggest an increase in schizophrenia population attributable risk fraction (PARF) for cannabis use disorder (CUD)....
